SCHEMBL13645447

SCHEMBL13645447

Cc1ccc(N)cc1-c1ccc2c(c1)NC(=O)C21CCCC1

nearest known ligand 0.71

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.71
RAF1 P04049 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1232289 0.83 MAPK14 (1.00) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL9375869 0.82 MAPK14 (0.49) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL1234146 0.82 MAPK14 (0.64) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL1232255 0.82 MAPK14 (0.81) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL2074236 0.81 MAPK14 (0.78) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL2074239 0.81 MAPK14 (0.78) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL1233836 0.81 MAPK14 (0.82) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL2076214 0.79 MAPK14 (1.00) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL2073330 0.79 MAPK14 (0.69) MAPK14RAF1CYP1A2CYP2C9CYP2C19
SCHEMBL1232243 0.79 MAPK14 (0.77) MAPK14RAF1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009124692-A1 NEW SUBSTITUTED SPIRO[CYCLOALKYL-1,3'-INDOL]-2'(1'H)-ONE DERIVATIVES AND THEIR USE AS P38 MITOGEN-ACTIVATED KINASE INHIBITORS. ALMIRALL, S.A. (ES) 2009-10-15 WO disclosed
EP-2108641-A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors Laboratorios Almirall, S.A. (ES) 2009-10-14 EP disclosed